CINECA IRIS Institutional Research Information System

MILLA, Paola
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 8.266
NA - Nord America 4.896
AS - Asia 1.771
SA - Sud America 61
AF - Africa 37
Continente sconosciuto - Info sul continente non disponibili 16
OC - Oceania 15
Totale 15.062
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 5.286
US - Stati Uniti d'America 4.798
CN - Cina 814
IE - Irlanda 524
FR - Francia 504
SE - Svezia 447
DE - Germania 353
FI - Finlandia 289
KR - Corea 267
UA - Ucraina 210
SG - Singapore 187
PL - Polonia 163
GB - Regno Unito 162
JP - Giappone 150
IN - India 99
VN - Vietnam 97
AT - Austria 80
CA - Canada 68
CH - Svizzera 47
ES - Italia 47
IL - Israele 39
BE - Belgio 35
NL - Olanda 28
SN - Senegal 27
MX - Messico 26
TR - Turchia 26
RO - Romania 25
BR - Brasile 22
IR - Iran 18
CO - Colombia 17
RU - Federazione Russa 17
AU - Australia 13
EU - Europa 13
TH - Thailandia 13
HK - Hong Kong 11
MY - Malesia 10
PT - Portogallo 9
ID - Indonesia 8
CZ - Repubblica Ceca 6
DK - Danimarca 6
EC - Ecuador 6
EG - Egitto 6
SA - Arabia Saudita 6
TW - Taiwan 6
GR - Grecia 5
PE - Perù 5
PY - Paraguay 5
LT - Lituania 4
UZ - Uzbekistan 4
AR - Argentina 3
CL - Cile 3
PH - Filippine 3
SM - San Marino 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
AP - ???statistics.table.value.countryCode.AP??? 2
AZ - Azerbaigian 2
BG - Bulgaria 2
CR - Costa Rica 2
CY - Cipro 2
HR - Croazia 2
IQ - Iraq 2
JO - Giordania 2
LU - Lussemburgo 2
MD - Moldavia 2
NZ - Nuova Zelanda 2
ZA - Sudafrica 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AF - Afghanistan, Repubblica islamica di 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CU - Cuba 1
GH - Ghana 1
HU - Ungheria 1
MC - Monaco 1
MT - Malta 1
NO - Norvegia 1
PA - Panama 1
PK - Pakistan 1
RS - Serbia 1
SC - Seychelles 1
Totale 15.062
Salva come PNG Salva come JPEG
Città #
Chandler 656
Beijing 533
Dublin 501
Houston 250
Fairfield 242
Ann Arbor 238
Milan 226
Rome 218
Torino 201
Villeurbanne 196
Ashburn 174
Medford 166
Dearborn 163
Princeton 161
Jacksonville 149
Warsaw 126
Wilmington 121
Singapore 120
Woodbridge 102
Pisa 94
Nyköping 90
Seattle 90
Cambridge 76
Vienna 75
Redwood City 68
Boardman 62
Dong Ket 60
Naples 59
Boston 53
Turin 52
Napoli 48
Munich 40
Palermo 38
Verona 34
Catania 32
Florence 31
Bologna 29
Bari 28
Hangzhou 28
New York 28
Toronto 27
Dallas 26
Genova 26
Guangzhou 26
Fremont 24
Tel Aviv 23
Brussels 22
Des Moines 22
Mountain View 22
Nanjing 22
Padova 22
Shanghai 21
Düsseldorf 19
Hefei 19
Brescia 18
Parma 18
Seongnam 18
Menlo Park 17
Lappeenranta 16
Erlangen 15
Norwalk 15
Ottawa 15
Duncan 14
Genoa 14
Washington 14
Monza 13
Pescara 13
Pune 13
Trieste 13
Helsinki 12
Messina 12
Vicenza 12
Durham 11
Glendale 11
Missaglia 11
San Diego 11
Delhi 10
Falls Church 10
Frankfurt am Main 10
Kuala Lumpur 10
Kunming 10
Los Angeles 10
Massa 10
Phoenix 10
Piemonte 10
Santa Clara 10
Seoul 10
Trento 10
Brindisi 9
Buffalo 9
Cagliari 9
Cinisello Balsamo 9
Fuzhou 9
Segrate 9
Tokyo 9
Valencia 9
Venezia 9
Zurich 9
Andover 8
Bangkok 8
Totale 6.511
Salva come PNG Salva come JPEG
Nome #
Somministrazione intravescicale di Mitomicina C in ipertermia nei carcinomi vescicali superficiali a rischio intermedio 3.567
L'alcol etilico nei farmaci chemioterapici antiblastici iniettabili: valutazioni ed implicazioni pratiche 1.649
Efficacy and safety of a new device for intravesical thermochemotherapy in non-grade 3 BCG recurrent NMIBC: a phase I–II study 364
Intravesical thermo-chemotherapy based on conductive heat: a first pharmacokinetic study with Mitomycin C in superficial transitional cell carcinoma patients 331
Validation of a simple and economic HPLC-UV method for the simultaneous determination of vancomycin, meropenem, piperacillin and tazobactam in plasma samples 276
Pharmacokinetic study to optimize the intravesical administration of gemcitabine 274
PEGylation of proteins and liposomes, a powerful and flexible strategy to improve the drug delivery 273
Antibiotic adjustment in CRRT 245
Farmacocinetica del paclitaxel in associazione con acido valproico nella terapia del tumore anaplastico della tiroide 213
Adherence to oral chemotherapy: Evidence from a randomised clinical trial 198
Messa a punto del metodo di estrazione e determinazione analitica, tramite HPLC, dell'amfotericina B su campioni ematici 170
Valproic Acid, a Histone Deacetylase Inhibitor, in Combination with Paclitaxel for Anaplastic Thyroid Cancer: Results of a Multicenter Randomized Controlled Phase II/III Trial 157
Glargine insulin loaded lipid nanoparticles: Oral delivery of liquid and solid oral dosage forms 155
Recent studies on the delivery of hydrophilic drugs in nanoparticulate systems. 154
Dual Constant Domain-Fab: A novel strategy to improve half-life and potency of a Met therapeutic antibody 153
Lipid nanoparticles as vehicles for oral delivery of insulin and insulin analogs: preliminary ex vivo and in vivo studies 153
Chemical and microbiological stability, anticoagulant efficacy and toxicity of 35 and 90 mM trisodium citrate solutions stored in plastic syringes 153
Preparation and characterization of novel poly(ethylene glycol) paclitaxel derivatives. 146
Analogs of squalene and oxidosqualene inhibit oxidosqualene cyclase of Trypanosoma cruzi expressed in Saccharomyces cerevisiae 144
A Pharmacokinetics Study to Optimize Intravesical Administration of Gemcitabine 139
Vaccini, sieri, immunoglobuline e anticorpi monoclonali 124
Targeted Cancer Therapy: The Roles Played by Antibody-Drug and Antibody-Toxin Conjugates 116
Hyaluronic Acid Conjugates as Vectors for the Active Targeting of Drugs, Genes and Nanocomposites in Cancer Treatment 106
Fenil vinil solfuri e metil vinil solfuri, inibitori specifici della ossidosqualene ciclasi di Trypanosoma cruzi e di S. cerevisiae. 98
Farmacocinetica della Gemcitabina (GEM) e del suo trifosfato (dFdCTP) in infusione prolungata a basse dosi in monochemioterapia in pazienti affetti da tumori solidi 98
Alternate scheduling of Gemcitabine (GEM) - Oxaliplatin (OXA) association in metastatic (MTS) or locally advanced (LA) pancreatic adenocarcinoma: a clinical and pharmacokinetic (pk) evaluation 97
I medicinali senza obbligo di prescrizione in Pediatria. Tra raccomandazioni e automedicazione 93
A first pharmacokinetic study of mitomycin C intravesical thermo-chemotherapy for the treatment of superficial transitional cell carcinoma, "Beyond the Abstract," by Paola Milla, et al. 92
Effects of the Molecular Weight of Hyaluronic Acid in a Carbon Nanotube Drug Delivery Conjugate 90
Vinyl sulfide derivatives of truncated oxidosqualene as selective inhibitors of oxidosqualene and squalene-hopene cyclases 89
PHARMACOKINETICS, PHARMACOLOGICAL STABILITY, SAFETY AND ACTIVITY OF MMC ADMINISTERED WITH A NEW HYPERTHERMIA DEVICE (UNITHERMIA) 89
A pharmacokinetics study to optimize intravesical administration of gemcitabine 87
Farmacocinetica dell’associazione di vinorelbina orale con doxorubicina liposomiale peghilata nel tumore mammario metastatico 84
29-methylidene-2,3-oxidosqualene derivatives as stereospecific mechanism-based inhibitors of liver and yeast oxidosqualene cyclase. 81
Anti-TNF-α drugs: pharmacoeconomic analysis and proper use in pharmacological treatment in rheumatoid arthritis 78
19-azasqualene-2,3-epoxide and its N-oxide: metabolic fate and inhibitory effect on sterol biosynthesis in Saccharomyces cerevisiae 76
Yeast Oxidosqualene cyclase (Erg7p) Is a Major Component of Lipid Particles. J. Biol. Chem. (2002) 277, 2406-2412. 75
Farmacocinetica della somministrazione alternata della Gemcitabina (GEM) e Oxaliplatino (OXA) nei tumori pancreatici e delle vie biliari 75
Vinyl sulfide derivatives of oxidosqualene, as inhibitors of oxidosqualene cyclase of Trypanosoma cruzi expressed in Saccharomyces cerevisiae. 74
Coagulation Factor VIII: pharmacoeconomic evaluation and quality of life as measuring tools in clinical practice 73
Pharmacokinetics, Pharmacological Stability, Safety and Efficacy of MMC Administered with a New Hyperthermia Device 73
Paclitaxel e doxorubicina liposomiale peghilata in tumori testa/collo recidivanti: un’inaspettata interazione farmacocinetica intervallo-dipendente relativa alla somministrazione 72
Association of Gemcitabine (GEM) and Oxaliplatin (OXA) in metastatic or locally advanced pancreatic adenocarcinoma: a clinical and pharmacokinetic (PK) study 71
Studio Farmacocinetico per determinare la modalità di somministrazione più idonea per la gemcitabina endovescicale 71
An independent study about over the counter medicines to analyse parents’ awareness for paediatric use 71
Design of specific tools to evaluate the Cost Of Illness (COI) of Rheumatoid Arthritis 70
Yeast Oxidosqualene cyclase (Erg7p) Is a Major Component of Lipid Particles 69
2,3-oxidosqualene cyclase from yeast: a target enzyme for drug discovery. 69
Administration of reduced glutathione in FOLFOX4 regimen in advanced colorectal cancer: effect on oxaliplatin pharmacokinetics and on Pt-DNA adducts formation 68
Subcellular localization of yeast oxidosqualene cyclase and other eukaryotic oxidosqualene cyclases expressed in yeast 68
3-carboxy-4-nitrophenyl-dithio-1,1'-2-trisnorsqualene: a site directed inactivator of yeast oxidosqualene cyclase 67
Synthesis and biological activity of aryldithio and maleimido squalene derivatives as new irreversible inhibitors of squalene 2,3-oxide-lanosterol cyclase. 65
Studio farmacocinetico del Paclitaxel in associazione con acido valproico nella terapia del tumore anaplastico della tiroide 65
The 3-keto reductase protein (Erg27p) is required for oxidosqualene cyclase (Erg7p) activity in yeast 65
Thiol-modifying agents as tools for understanding the function of squalene cyclase 65
Subcutaneous vs. intravenous immunoglobulin in CIDP: pharmacokinetic and clinical response 65
Thiol-modifying Inhibitors for Understanding Squalene Cyclase Function. Eur. J. Biochem. (2002) 269, 2108-2116. 64
polyclonal antibodies against a fragment of oxidosqualene cyclase(erg7p) overexpressed in E.coli recognize the enzyme of different sources 64
PHARMACOKINETICS, PHARMACOLOGICAL STABILITY AND SAFETY OF MMC ADMINISTERED WITH A NEW HYPERTHERMIA DEVICE 64
Economic evaluation of different modalities of immunoglobulin therapy in chronic dysimmune polyradiculoneuropathies 64
Systematic analysis of yeast strains with possible defects in lipid metabolism 62
Synthesis of novel 4,5-diphenylthiazole derivatives as potential acyl-CoA: cholesterol O-acyltransferase inhibitors 62
Herbal Medicines in Children: between advice-giving and self-medication 62
Inhibition of sterol biosynthesis in Saccharomyces cerevisiae and Candida albicans by 22,23-epoxy-2-aza-2,3-dihydrosqualene and the corresponding N-oxide. 61
Preparation and characterization of novel PEG-paclitaxel derivatives 61
Administration of reduced glutathione in FOLFOX4 adjuvant treatment for colorectal cancer: effect on oxaliplatin pharmacokinetics, Pt-DNA adduct formation, and neurotoxicity. 61
Comparison of the mechanism of yeast oxidosqualene cyclase and bacterial squalene cyclase by using rationally designed inhibitors. 59
Comparative properties of N-ethoxycarbonyl-D-phenylalanyl-L-prolyl-alpha-azalysine p-nitrophenyl ester and N-ethoxycarbonyl-D-phenylalanyl-alpha-azaprolyl-L-lysine p-nitrophenyl ester as subsrates of serine proteinases 59
Ottimizzazione della somministrazione endovescicale di gemcitabina: uno studio farmacocinetico 59
Yeast oxidosqualene cyclase (Erg7p) is a major component of lipid particles 58
Self-Assembled Squalene-based Fluorescent Heteronanoparticles 58
Active site titration of bovine beta-trypsin by N alpha-(N,N-dimethylcarbamoyl)-alpha-aza-lysine p-nitrophenyl ester: kinetic and crystallographic analysis 57
Evidence of the existence of an essential thiol group within the active site of oxidosqualene cyclase from Saccharomyces cerevisiae 56
The effect of five different administration intervals on the pharmacokinetics (pk) of paclitaxel (PTX) and pegylated liposomal doxorubicin (PLD) association regimen 55
Studio farmacocinetico e tossicologico dell’effetto neuroprotettivo del glutatione ridotto sulla chemioterapia basata sull’oxaliplatino nel carcinoma colon-rettale avanzato 54
Subcellular localization of oxidosqualene cyclases from Arabidopsis thaliana, Trypanosoma cruzi and Pneumocystis carinii expressed in yeast 54
Stereospecific inhibition of sterol biosynthesis in HEP G2 and Saccharomyces cerevisiae cell cultures by 29-methylidene-oxidosqualene derivatives. 53
Studio farmacocinetico dell’associazione di vinorelbina (VNR) per via orale con doxorubicina liposomale peghilata (PLD) nel carcinoma mammario metastatico 53
Effect of proteases on microsomal oxidosqualene cyclases from Saccharomyces cerevisiae and Candida albicans 53
Sterospecific irreversible inhibitors of liver and yeast oxidosqualene cyclase 53
Study of sequence-dependent pharmacokinetic interactions between oral vinorelbine (VNR) and pegylated liposomal doxorubicin (PLD) in metastatic ovarian carcinoma 52
Human alpha-thrombin inhibition by the highly selective compounds N-ethoxycarbonyl-D-Phe-Pro-alpha-azaLys p-nitrophenyl ester and N-carbobenzoxy-Pro-alpha-azaLys p-nitrophenyl ester: a kinetic, thermodynamic and X-ray crystallographic study 52
Stereospecific synthesis of trans-vinyl dioxidosqualene and b-hydrosulfide derivatives, as potent and time-dependent 2,3-oxidosqualene cyclase inhibitors 51
The impact of five different administration intervals on the pharmacokinetics (PK) of paclitaxel (PTX) and pegylated liposomal doxorubicin (PLD) combination 51
Nanotechnology Addressing Cutaneous Melanoma: The Italian Landscape 51
Clinical Assessment of Continuous Hemodialysis with the Medium Cutoff EMiC ® 2 Membrane in Patients with Septic Shock 51
Conjugated Methyl Sulfide and phenyl Sulfide Derivatives of Oxidosqualene as Inhibitors of Oxidosqualene and Squalene-Hopene Cyclases. 50
Synthesis and in vitro evaluation of new 4,5-diphenylthiazole derivatives as acyl-CoA:cholesterol O-acyl transferase inhibitors 50
In vitro metabolic fate of D2-thiazoline ring: evidence for the formation of a reactive metabolite in enzymatic-dependent D2-thiazoline ring cleavage 50
Topology of DNA: when manipulation supports the lack of “space-filling” imagination 49
Synthesis and biological activity of new iodoacetamide derivatives on mutants of squalene-hopene cyclase 49
Effects of reduced glutathione (GSH) on oxaliplatin (OXA) in advanced colorectal cancer treated by FOLFOX4 regimen: Pharmacokinetics (PK) and determination of PtDNA adducts 48
Squalene- and nonsqualene-like thiol modifying agents as tools for understanding the function of squalene-hopene cyclase 47
Subcellular distribution and selective inhibition of oxidosqualene cyclases of Trypanosoma cruzi and Pneumocystis carinii expressed in Saccharomyces cerevisiae 46
Paclitaxel and pegylated liposomal doxorubicin in recurrent head and neck cancer: Clinical and unexpected pharmacokinetic interactions 45
Paclitaxel and pegylated liposomal doxorubicin in recurrent head/neck cancer: clinical and pharmacokinetic preliminary data 44
Medicinali biologici ad alto costo e ad alta spesa nell'artrite reumatoide: tra sostenibilità ed opportunità 44
Radiofarmaci 44
Nanotechnological approaches for pentamidine delivery 43
Pharmacokinetic (PK) evaluation of 2’,2’-Difluorodeoxycytidine-5’-triphosphate (dFdCTP) and gemcitabine (GEM) as prolonged infusion in monochemotherapy in patients affected by solid tumors 42
Totale 14.168
Salva come PNG Salva come JPEG
Categoria #
all - tutte 35.373
article - articoli 0
book - libri 0
conference - conferenze 16.291
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.664
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.903 0 0 213 218 173 326 211 124 154 150 172 162
2020/20212.365 255 139 154 179 270 155 203 127 260 218 172 233
2021/20221.828 95 97 91 115 137 109 117 136 62 101 376 392
2022/20232.647 273 162 124 260 247 556 256 161 248 103 156 101
2023/20241.447 136 214 117 95 83 138 62 82 21 153 138 208
2024/2025279 91 143 45 0 0 0 0 0 0 0 0 0
Totale 15.573